Amwise Diagnostic
About:
Amwise Diagnostic is a leader in precision medicine technology for cancer.
Website: https://www.amwisediagnostics.com/
Top Investors: WI Harper Group, Simcere Pharma, Alibaba Entrepreneurs Fund, Lippo Group
Description:
Amwise Diagnostic is a leader in precision medicine technology for cancer. Our patented genetic analysis technologies assist doctors and patients in determining the most appropriate individualized treatment strategy that has optimal treatment effectiveness and minimal treatment-related adverse events.
Total Funding Amount:
$10M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Taipei, T'ai-pei, Taiwan
Founded Date:
2015-01-01
Contact Email:
service(AT)amwisediagnostics.com
Founders:
Xianlin Huang
Number of Employees:
11-50
Last Funding Date:
2020-02-26
IPO Status:
Private
Industries:
© 2025 bioDAO.ai